Target intelligence / Profile preview

Armadillo-like helical domain-containing protein 4 (ARMH4)

Target
ARMH4
Molecular classification
Other (Armadillo repeat/helical domain-containing protein), Membrane-associated protein
01

Overview

Armadillo-like helical domain-containing protein 4 (ARMH4) is a membrane-associated protein encoded by the ARMH4 gene (also known as C14orf37 and other aliases) on human chromosome 14[2][6]. ARMH4 contains armadillo-like helical repeats, is highly conserved across vertebrates, and is predicted to bind the TORC2 (mTOR complex 2) signaling complex[2][3]. It is expressed dynamically during embryonic development, prominently in the cardiac progenitor fields (first and second heart field) and in various neural tissues in the mouse embryo, with declining expression postnatally[1]. In human studies, ARMH4 is involved in the modulation of immune and inflammatory responses and exerts negative regulatory effects on AKT (via mTORC2/RICTOR interaction) and STAT3 (via IL6ST interaction) signaling pathways[2][5][7]. Although it is associated with some disease processes (e.g., arrhythmogenic right ventricular cardiomyopathy, inflammation, cancer via signaling roles), ARMH4 is not currently a validated therapeutic target and has no known interacting drugs or mechanisms of therapeutic modulation[2][5][7]. It is also considered a specific biomarker for certain cardiomyocyte progenitor populations during heart development[1].

Other names
C14orf37UT2Upstream of mTORC2 proteinupstream of mTORC2c14_5376uncharacterized protein C14orf37
02

Biological functions

Regulation of inflammatory responseNegative regulation of AKT signaling via mTORC2Down-modulation of STAT3 signaling (via IL6ST interaction)Modulation of immune response
03

Disease associations

Arrhythmogenic right ventricular cardiomyopathy (genetic association; not a validated therapeutic target)Potential contributor to inflammation, adult hematopoietic malignancies (based on signaling pathways involved)
04

Biomarkers

Marker for first and second heart field (FHF/SHF) cardiomyocyte progenitors during embryonic heart development

Beyond the preview

Go deeper on Armadillo-like helical domain-containing protein 4 (ARMH4).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Armadillo-like helical domain-containing protein 4 (ARMH4).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call